Sodium in PDB 7zzr: HDAC2 in Complex with Inhibitory Ligand
Enzymatic activity of HDAC2 in Complex with Inhibitory Ligand
All present enzymatic activity of HDAC2 in Complex with Inhibitory Ligand:
3.5.1.98;
Protein crystallography data
The structure of HDAC2 in Complex with Inhibitory Ligand, PDB code: 7zzr
was solved by
A.Cleasby,
D.Tisi,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
76.69 /
2.17
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
91.991,
97.7,
138.849,
90,
90,
90
|
R / Rfree (%)
|
18.8 /
24.7
|
Other elements in 7zzr:
The structure of HDAC2 in Complex with Inhibitory Ligand also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the HDAC2 in Complex with Inhibitory Ligand
(pdb code 7zzr). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 3 binding sites of Sodium where determined in the
HDAC2 in Complex with Inhibitory Ligand, PDB code: 7zzr:
Jump to Sodium binding site number:
1;
2;
3;
Sodium binding site 1 out
of 3 in 7zzr
Go back to
Sodium Binding Sites List in 7zzr
Sodium binding site 1 out
of 3 in the HDAC2 in Complex with Inhibitory Ligand
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of HDAC2 in Complex with Inhibitory Ligand within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na603
b:21.2
occ:1.00
|
O
|
A:VAL198
|
2.2
|
15.8
|
1.0
|
O
|
A:PHE192
|
2.3
|
17.3
|
1.0
|
O
|
A:HOH750
|
2.5
|
16.6
|
1.0
|
O
|
A:THR195
|
2.6
|
17.4
|
1.0
|
O
|
A:HOH842
|
2.7
|
20.8
|
1.0
|
C
|
A:VAL198
|
3.4
|
15.4
|
1.0
|
C
|
A:PHE192
|
3.4
|
17.3
|
1.0
|
O
|
A:TYR227
|
3.4
|
16.6
|
1.0
|
CB
|
A:TYR227
|
3.7
|
18.2
|
1.0
|
C
|
A:THR195
|
3.8
|
17.9
|
1.0
|
CB
|
A:PHE192
|
3.9
|
14.6
|
1.0
|
C
|
A:TYR227
|
4.0
|
16.2
|
1.0
|
N
|
A:MET199
|
4.3
|
14.9
|
1.0
|
CA
|
A:MET199
|
4.3
|
16.2
|
1.0
|
CA
|
A:PHE192
|
4.3
|
16.2
|
1.0
|
CG2
|
A:THR195
|
4.3
|
21.3
|
1.0
|
N
|
A:TYR193
|
4.3
|
17.4
|
1.0
|
N
|
A:THR195
|
4.4
|
17.7
|
1.0
|
CA
|
A:TYR193
|
4.4
|
17.9
|
1.0
|
CA
|
A:VAL198
|
4.4
|
15.0
|
1.0
|
C
|
A:TYR193
|
4.5
|
17.9
|
1.0
|
O
|
A:TYR193
|
4.5
|
16.3
|
1.0
|
CA
|
A:TYR227
|
4.5
|
17.5
|
1.0
|
N
|
A:VAL198
|
4.6
|
16.8
|
1.0
|
CA
|
A:THR195
|
4.6
|
18.1
|
1.0
|
CB
|
A:VAL198
|
4.6
|
13.5
|
1.0
|
N
|
A:THR200
|
4.7
|
14.7
|
1.0
|
O
|
A:GLY224
|
4.7
|
22.0
|
1.0
|
N
|
A:ALA228
|
4.7
|
16.3
|
1.0
|
CA
|
A:GLY224
|
4.8
|
21.9
|
1.0
|
N
|
A:ASP196
|
4.8
|
18.5
|
1.0
|
C
|
A:MET199
|
4.9
|
16.9
|
1.0
|
CG2
|
A:THR200
|
4.9
|
12.9
|
1.0
|
OG1
|
A:THR200
|
4.9
|
12.6
|
1.0
|
CG
|
A:TYR227
|
4.9
|
19.4
|
1.0
|
|
Sodium binding site 2 out
of 3 in 7zzr
Go back to
Sodium Binding Sites List in 7zzr
Sodium binding site 2 out
of 3 in the HDAC2 in Complex with Inhibitory Ligand
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of HDAC2 in Complex with Inhibitory Ligand within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na603
b:15.1
occ:1.00
|
O
|
B:PHE192
|
2.3
|
16.3
|
1.0
|
O
|
B:VAL198
|
2.3
|
13.5
|
1.0
|
O
|
B:HOH777
|
2.3
|
8.5
|
1.0
|
O
|
B:THR195
|
2.5
|
15.4
|
1.0
|
O
|
B:HOH794
|
2.7
|
20.5
|
1.0
|
C
|
B:PHE192
|
3.4
|
16.3
|
1.0
|
O
|
B:TYR227
|
3.5
|
16.9
|
1.0
|
C
|
B:VAL198
|
3.5
|
12.9
|
1.0
|
CB
|
B:TYR227
|
3.7
|
18.4
|
1.0
|
C
|
B:THR195
|
3.7
|
15.5
|
1.0
|
CB
|
B:PHE192
|
4.0
|
16.0
|
1.0
|
C
|
B:TYR227
|
4.0
|
16.7
|
1.0
|
N
|
B:THR195
|
4.2
|
17.9
|
1.0
|
CG2
|
B:THR195
|
4.3
|
17.2
|
1.0
|
CA
|
B:PHE192
|
4.3
|
16.8
|
1.0
|
N
|
B:TYR193
|
4.3
|
16.4
|
1.0
|
CA
|
B:TYR193
|
4.3
|
17.5
|
1.0
|
C
|
B:TYR193
|
4.3
|
19.3
|
1.0
|
O
|
B:TYR193
|
4.4
|
20.9
|
1.0
|
N
|
B:MET199
|
4.4
|
11.1
|
1.0
|
CA
|
B:MET199
|
4.4
|
11.5
|
1.0
|
CA
|
B:VAL198
|
4.5
|
15.5
|
1.0
|
CA
|
B:THR195
|
4.5
|
16.6
|
1.0
|
CA
|
B:TYR227
|
4.5
|
17.8
|
1.0
|
N
|
B:VAL198
|
4.6
|
16.1
|
1.0
|
O
|
B:GLY224
|
4.6
|
22.4
|
1.0
|
CA
|
B:GLY224
|
4.6
|
23.2
|
1.0
|
CB
|
B:VAL198
|
4.7
|
18.0
|
1.0
|
N
|
B:ASP196
|
4.7
|
14.9
|
1.0
|
N
|
B:ALA228
|
4.7
|
16.4
|
1.0
|
N
|
B:THR200
|
4.8
|
11.3
|
1.0
|
CG
|
B:TYR227
|
4.9
|
19.3
|
1.0
|
N
|
B:THR194
|
4.9
|
18.2
|
1.0
|
CA
|
B:ASP196
|
5.0
|
14.9
|
1.0
|
|
Sodium binding site 3 out
of 3 in 7zzr
Go back to
Sodium Binding Sites List in 7zzr
Sodium binding site 3 out
of 3 in the HDAC2 in Complex with Inhibitory Ligand
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 3 of HDAC2 in Complex with Inhibitory Ligand within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Na603
b:30.7
occ:1.00
|
O
|
C:HOH762
|
2.3
|
11.0
|
1.0
|
O
|
C:PHE192
|
2.3
|
17.7
|
1.0
|
O
|
C:THR195
|
2.4
|
18.8
|
1.0
|
O
|
C:VAL198
|
2.4
|
21.1
|
1.0
|
O
|
C:HOH796
|
2.9
|
21.5
|
1.0
|
C
|
C:PHE192
|
3.4
|
18.0
|
1.0
|
O
|
C:TYR227
|
3.6
|
20.9
|
1.0
|
C
|
C:THR195
|
3.6
|
18.8
|
1.0
|
C
|
C:VAL198
|
3.6
|
20.1
|
1.0
|
CB
|
C:TYR227
|
3.6
|
22.2
|
1.0
|
CB
|
C:PHE192
|
4.1
|
19.1
|
1.0
|
C
|
C:TYR227
|
4.1
|
21.2
|
1.0
|
N
|
C:THR195
|
4.1
|
18.4
|
1.0
|
CG2
|
C:THR195
|
4.2
|
21.9
|
1.0
|
C
|
C:TYR193
|
4.3
|
18.3
|
1.0
|
O
|
C:TYR193
|
4.3
|
18.3
|
1.0
|
CA
|
C:TYR193
|
4.3
|
18.9
|
1.0
|
N
|
C:TYR193
|
4.3
|
17.7
|
1.0
|
CA
|
C:THR195
|
4.3
|
19.5
|
1.0
|
CA
|
C:PHE192
|
4.4
|
18.6
|
1.0
|
CA
|
C:GLY224
|
4.4
|
22.0
|
1.0
|
CA
|
C:TYR227
|
4.5
|
22.8
|
1.0
|
O
|
C:GLY224
|
4.5
|
23.5
|
1.0
|
N
|
C:MET199
|
4.5
|
19.6
|
1.0
|
CA
|
C:MET199
|
4.5
|
20.8
|
1.0
|
CA
|
C:VAL198
|
4.5
|
18.0
|
1.0
|
N
|
C:VAL198
|
4.6
|
18.6
|
1.0
|
N
|
C:ASP196
|
4.6
|
18.6
|
1.0
|
N
|
C:ALA228
|
4.8
|
20.4
|
1.0
|
CG
|
C:TYR227
|
4.8
|
22.1
|
1.0
|
CB
|
C:VAL198
|
4.8
|
16.2
|
1.0
|
CA
|
C:ASP196
|
4.8
|
21.1
|
1.0
|
N
|
C:THR194
|
4.9
|
17.4
|
1.0
|
CB
|
C:THR195
|
4.9
|
21.9
|
1.0
|
N
|
C:THR200
|
4.9
|
20.1
|
1.0
|
C
|
C:GLY224
|
5.0
|
22.6
|
1.0
|
|
Reference:
E.Tamanini,
S.Miyamura,
I.M.Buck,
B.D.Cons,
L.Dawson,
C.East,
T.Futamura,
S.Goto,
C.Griffiths-Jones,
T.Hashimoto,
T.D.Heightman,
S.Ishikawa,
H.Ito,
Y.Kaneko,
T.Kawato,
K.Kondo,
N.Kurihara,
J.M.Mccarthy,
Y.Mori,
T.Nagase,
Y.Nakaishi,
J.Reeks,
A.Sato,
P.Schopf,
K.Tai,
T.Tamai,
D.Tisi,
A.J.Woolford.
Fragment-Based Discovery of A Novel, Brain Penetrant, Orally Active HDAC2 Inhibitor. Acs Med.Chem.Lett. V. 13 1591 2022.
ISSN: ISSN 1948-5875
PubMed: 36262388
DOI: 10.1021/ACSMEDCHEMLETT.2C00272
Page generated: Wed Oct 9 10:21:41 2024
|